A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

3.0.0 4084 2023-01-11T13:38:24Z 2023-01-11T13:38:24Z House HR 2017-10-19 115 [Congressional Record Volume 163, Number 169 (Thursday, October 19, 2017)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. KUSTER of New Hampshire:H.R. 4084.Congress has the power to enact this legislation pursuantto the following:Under Article I, Section 8, Clause 3 of the Constitution,Congress has the power ``to regulate commerce with foreignnations, and among the several states, and with the Indiantribes,'' and under Article I, Section 8, Clause 18, Congresshas the power ``to make all laws which shall be necessary andproper for the carrying into execution the foregoing powers,and all other powers vested by this Constitution in thegovernment of the United States, or in any department orofficer thereof.''[Page H8042]]]> hsju00 Judiciary Committee House Standing hsju08 Crime and Federal Government Surveillance Subcommittee Referred to 2017-11-01T19:29:32Z Referred to 2017-10-19T16:01:35Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2017-10-20T19:48:42Z Referred to 2017-10-19T16:01:30Z A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. 115 1960 S 2017-10-16 Read twice and referred to the Committee on the Judiciary. Identical bill CRS 2017-11-01 hsju08 Crime and Federal Government Surveillance Subcommittee 1 House committee actions Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. Committee 2017-10-20 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2017-10-19 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2017-10-19 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2017-10-19 Introduced in House IntroReferral Intro-H 9 Library of Congress 2017-10-19 Introduced in House IntroReferral 1000 9 Library of Congress K000382 Rep. Kuster, Ann M. [D-NH-2] Ann Kuster D NH M. 2 N J000297 Rep. Jenkins, Evan H. [R-WV-3] Evan Jenkins R WV H. 3 2017-10-19 True R000577 Rep. Ryan, Tim [D-OH-13] TIM RYAN D OH 13 2017-10-19 True C000754 Rep. Cooper, Jim [D-TN-5] JAMES COOPER D TN H. 5 2017-10-19 True E000293 Rep. Esty, Elizabeth H. [D-CT-5] Elizabeth Esty D CT H. 5 2017-11-29 False D000399 Rep. Doggett, Lloyd [D-TX-35] LLOYD DOGGETT D TX 35 2017-11-29 False C001068 Rep. Cohen, Steve [D-TN-9] Steve Cohen D TN 9 2017-12-01 False D000617 Rep. DelBene, Suzan K. [D-WA-1] Suzan DelBene D WA K. 1 2017-12-01 False J000032 Rep. Jackson Lee, Sheila [D-TX-18] SHEILA JACKSON LEE D TX 18 2017-12-01 False Crime and Law Enforcement Drug trafficking and controlled substances Licensing and registrations Prescription drugs Retail and wholesale trades Crime and Law Enforcement

00 2017-10-19 Introduced in House 2019-08-07T22:13:25Z This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances.

]]>

To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. Display Title To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. Official Title as Introduced To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. Introduced in House 2017-10-19T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115hr4084ih/xml/BILLS-115hr4084ih.xml 2017-11-01 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.